인쇄하기
취소

Dr. Choi Ju-hyon named to head Sanofi Aventis Korea’s R&D operations

Published: 2013-06-10 06:57:00
Updated: 2013-06-10 06:57:00
Sanofi Aventis Korea said Wednesday it has appointed as its research development director, Choi Ju-yeon, a world-renowned expert in developing new drugs.

Choi will take charge of reinforcing open innovation and partnership strategy through a decentralized and non-authoritative R&D organization and also focusing on translational medicine.

“Previously at LG Life Sciences, he has spearheade...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.